Member - Syngulon

Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins.

Type Startup or self-employed
Founded 2013
Company Size 10
Member Type
innovator
Founders Dr Philippe Gabant & Guy Hélin
Headquarters 4102 Seraing, Belgium
Social network
Syngulon

About

Bacteriocins are natural antimicrobial peptides produced by bacteria. At Syngulon, a synthetic biology startup, we have a collection of bacteriocins, called PARAGEN, that can be used alone or in cocktail in order to avoid using antibiotics or other chemicals that are very negative for the environment.
Headquarters 4102 Seraing, Belgium

SDG’s of application

The Sustainable Development Goals are a call to action to end poverty, protect the planet and ensure peace and prosperity everywhere.
SDG 6
Clean water and sanitation
SDG 6 icon
SDG 7
Affordable and clean energy
SDG 7 icon
SDG 9
Industry, innovation and infrastructure
SDG 9 icon
SDG 11
Sustainable cities and communities
SDG 11 icon
SDG 12
Responsible consumption and production
SDG 12 icon

The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. To validate the Membership to the World Alliance for Efficient Solutions, the Solar Impulse Foundation only verifies that each entity is registered and has signed our principles and values stated in the following World Alliance for Efficient Solutions charter. For those Members who are also solution providers, this information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.